Evidence map›Paper›PMID 41719307›Full record

ArticlePLOS digital health2026

Machine learning based classification of aggressive and malignant renal tumors from multimodal data.

Mehrnegar Aminy, Tejal Gala, Agnimitra Dasgupta, Serena Li, Steven Y Cen, S J Pawan, Inderbir Gill, Vinay Duddalwar, Assad A Oberai

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mehrnegar AminyDepartment of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California (USC), Los Angeles, California, United States of America.
Tejal GalaDepartment of Radiology, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-3799-7671
Agnimitra DasguptaDepartment of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California (USC), Los Angeles, California, United States of America.
Serena LiDepartment of Computer Science, Viterbi School of Engineering, University of Southern California (USC), Los Angeles, California, United States of America.
Steven Y CenKeck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
S J PawanDepartment of Radiology, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Inderbir GillUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology Keck School of Medicine, University of Southern California (USC), Los Angeles, California, United States of America.
Vinay DuddalwarRadiomics Lab, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Assad A OberaiDepartment of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California (USC), Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-7668-7713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to develop and evaluate a machine learning pipeline using multiphase contrast-enhanced CT images and clinical data to classify renal tumors as benign, malignant-indolent, or malignant-aggressive, while assessing the contribution of each data source to the classification. In this retrospective study, 448 patients (mean age: 60.7 ± 12.6 years, 306 male, 142 female) who underwent nephrectomy and preoperative CECT between June 2008 and July 2018 were included. Tumors were histologically categorized as benign-indolent, malignant-indolent, or malignant-aggressive. Self-supervised feature extraction converted 4-phase CECT images into 512 real-valued features, combined with clinical data and tumor size for classification. Two machine learning classifiers, random forest (RF) and multi-layer perceptron (MLP), were used to predict tumor type. Nested five-fold cross-validation was employed for hyperparameter tuning and model evaluation, and performance was assessed using area under the curve (AUC) analysis. The best-performing models achieved an AUC of 0.90 (95% CI: 0.88-0.93) for classifying indolent versus aggressive tumors and 0.76 (95% CI: 0.71-0.81) for malignant versus benign tumors. Models incorporating tumor size significantly improved classification accuracy. RF classifiers excelled in distinguishing indolent from aggressive tumors, while MLP classifiers performed better for malignant versus benign classification. The machine learning pipeline demonstrated high accuracy in differentiating aggressive from indolent renal tumors, offering valuable prognostic insights for personalized treatment. Tumor size was a critical factor, complementing CECT images and clinical data. These findings highlight the potential of ML techniques in enhancing renal tumor risk stratification.

Identifiers

PMID41719307
PMCPMC12923042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.